Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-32652-3
Abstract: Cancers are driven by a variety of somatic gene mutations and identifying these mutations enables the development of novel target drugs. We have sought to identify abnormalities in Wnt pathway-related genes that are sensitive to… read more here.
Keywords: treatment; porcupine inhibitor; rspo2 fusion; fusion ... See more keywords